sulpiride has been researched along with Drug Withdrawal Symptoms in 28 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The drug was injected intramuscularly in a single administration at a dosage of 600 mg." | 2.66 | Effect of sulpiride on chronic abstinence syndrome in addicted patients. ( Drago, F; Marano, P; Nicoletti, F; Patti, F; Scapagnini, U, 1986) |
| "4." | 1.28 | Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment. ( Hietala, J; Röyttä, M; Syvälahti, E, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (53.57) | 18.7374 |
| 1990's | 9 (32.14) | 18.2507 |
| 2000's | 4 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendhekar, D | 1 |
| Lohia, D | 1 |
| Alonso-Navarro, H | 1 |
| Jiménez-Jiménez, FJ | 1 |
| Zharkovskiĭ, AM | 1 |
| Zharkovskaia, TA | 1 |
| Rizzo, F | 1 |
| Ferrari, F | 1 |
| Baggio, G | 1 |
| Montanaro, N | 2 |
| Dall'Olio, R | 2 |
| Gandolfi, O | 2 |
| Vaccheri, A | 2 |
| Iruela, LM | 1 |
| Caballero, L | 1 |
| Ibánez-Rojo, V | 1 |
| Palanca, I | 1 |
| Zarrindast, MR | 2 |
| Farzin, D | 2 |
| Rezayat, M | 1 |
| Azizi, N | 1 |
| Obuchowicz, E | 1 |
| Turchan, J | 1 |
| Lu, L | 1 |
| Su, WJ | 1 |
| Yue, W | 1 |
| Ge, X | 1 |
| Su, F | 1 |
| Pei, G | 1 |
| Ma, L | 1 |
| Marchese, G | 1 |
| Casu, MA | 1 |
| Bartholini, F | 1 |
| Ruiu, S | 1 |
| Saba, P | 1 |
| Gessa, GL | 1 |
| Pani, L | 1 |
| Carrère, J | 1 |
| Roux, JM | 1 |
| Piredda, F | 1 |
| Cugurra, F | 1 |
| Canevari, A | 1 |
| Caroli, F | 1 |
| Littre-Poirier, MF | 1 |
| Ginestet, D | 1 |
| Deniker, P | 1 |
| Planche, S | 1 |
| Klippel, E | 1 |
| la Barre, J | 1 |
| De Permentier, A | 1 |
| Kaliszuk, S | 1 |
| Borzecki, Z | 1 |
| Swies, Z | 1 |
| Benazzi, F | 1 |
| Friedman, E | 1 |
| Wang, HY | 1 |
| Butkerait, P | 1 |
| Brent, PJ | 1 |
| Chahl, LA | 1 |
| Hietala, J | 1 |
| Syvälahti, E | 1 |
| Röyttä, M | 1 |
| Fava, GA | 1 |
| Grandi, S | 1 |
| Saviotti, FM | 1 |
| Conti, S | 1 |
| Bartolucci, G | 1 |
| Savron, G | 1 |
| Patti, F | 1 |
| Drago, F | 1 |
| Marano, P | 1 |
| Nicoletti, F | 1 |
| Scapagnini, U | 1 |
3 trials available for sulpiride and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
[Trial of interruption of antiparkinson drugs in long term treatments with neuroleptics].
Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Fluph | 1975 |
[Sulpiride and drug addiction].
Topics: Adolescent; Adult; Anxiety; Clinical Trials as Topic; Delusions; Female; Hallucinations; Humans; Lys | 1975 |
Effect of sulpiride on chronic abstinence syndrome in addicted patients.
Topics: Adolescent; Adult; Animals; Brain; Female; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Mal | 1986 |
25 other studies available for sulpiride and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Amisulpride and galactorrhoea: delayed or withdrawal?
Topics: Adult; Amisulpride; Antipsychotic Agents; Female; Galactorrhea; Humans; Receptors, Dopamine D2; Rece | 2009 |
Tardive blepharospasm beginning after withdrawal of veralipride.
Topics: Antipsychotic Agents; Blepharospasm; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Substanc | 2006 |
[Changes in the number of benzodiazepine receptors in different parts of the brain of rats after neuroleptic withdrawal].
Topics: Animals; Antipsychotic Agents; Brain; Clozapine; Flunitrazepam; Haloperidol; Humans; Male; Rats; Rat | 1984 |
[The need for psychopharmacologic therapy of drug addicts with acute hepatitis].
Topics: Acute Disease; Diazepam; Drug Therapy, Combination; Hepatitis; Heroin Dependence; Humans; Methadone; | 1984 |
Influence of lisuride on morphine withdrawal signs in the rat: a dopamine-mimetic effect.
Topics: Aggression; Animals; Apomorphine; Dopamine; Ergolines; Haloperidol; Humans; Lisuride; Male; Morphine | 1982 |
Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
Topics: Animals; Apomorphine; Behavior, Animal; Exploratory Behavior; Haloperidol; Humans; Male; Motor Activ | 1982 |
Behavioral supersensitivity to methamphetamine following chronic treatment with (--)-sulpiride in the rat.
Topics: Animals; Behavior, Animal; Drug Interactions; Haloperidol; Humans; Male; Methamphetamine; Motor Acti | 1981 |
Panic-like symptoms after veralipride withdrawal.
Topics: Female; Humans; Menopause; Middle Aged; Norepinephrine; Panic Disorder; Psychophysiologic Disorders; | 1993 |
Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice.
Topics: Animals; Atropine; Behavior, Animal; Benzazepines; Hexamethonium; Male; Mecamylamine; Mice; Morphine | 1996 |
On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice.
Topics: Adrenergic Antagonists; Animals; Atropine; Benzazepines; Ceruletide; Dopamine Antagonists; Male; Met | 1997 |
Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Dopamine Antagonists; Dopamine D2 Receptor Antagonist | 1999 |
Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Dextromethorphan; Domperidone; Dopamine Agonis | 1999 |
Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.
Topics: Adrenergic Uptake Inhibitors; Animals; Conditioning, Psychological; Cyclohexanols; Dopamine Antagoni | 2001 |
Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
Topics: Amisulpride; Animals; Antipsychotic Agents; Clozapine; Dopamine; Dose-Response Relationship, Drug; D | 2002 |
[Sulpiride in the withdrawal of non-ethylic drug addiction].
Topics: Anti-Anxiety Agents; Antiparkinson Agents; Female; Humans; Hypnotics and Sedatives; Male; Meperidine | 1976 |
[Detoxication of heroin addicts in the area of Genoa].
Topics: Adolescent; Adult; Amino Acids; Clonidine; Diazepam; Female; Fructose; Heroin Dependence; Humans; Ma | 1979 |
[Sulpiride in the rehabilitation of alcoholics].
Topics: Alcoholism; Humans; Substance Withdrawal Syndrome; Sulpiride | 1975 |
[Sulpiride treatment of the withdrawal syndrome in heroin-addicted dogs].
Topics: Animals; Disease Models, Animal; Dogs; Heroin Dependence; Humans; Substance Withdrawal Syndrome; Sul | 1975 |
Letter: Sulpiride as a demorphinization agent.
Topics: Adolescent; Adult; Animals; Dogs; Humans; Morphine Dependence; Substance Withdrawal Syndrome; Sulpir | 1976 |
The influence of agonists and antagonists of dopaminergic system on the formation of audiogenic seizures in rats during the ethanol abstinence period.
Topics: Amantadine; Animals; Bromocriptine; Dopamine Agents; Dopamine Antagonists; Ethanol; Haloperidol; Mal | 1990 |
Lorazepam, amitriptyline, and sulpiride: withdrawal effects.
Topics: Amitriptyline; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lo | 1991 |
Decreased striatal release of acetylcholine following withdrawal from long-term treatment with haloperidol: modulation by cholinergic, dopamine-D1 and -D2 mechanisms.
Topics: Acetylcholine; Animals; Benzazepines; Corpus Striatum; Haloperidol; In Vitro Techniques; Male; Paras | 1990 |
The effects of selective dopamine D-1 and D-2 antagonists on the locomotor response and brain monoamine changes induced by naloxone-precipitated morphine withdrawal in guinea pigs.
Topics: Animals; Benzazepines; Brain; Dopamine; Dopamine Antagonists; Guinea Pigs; Morphine; Motor Activity; | 1990 |
Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment.
Topics: Animals; Cerebral Cortex; Corpus Striatum; Fluphenazine; Kinetics; Male; Quinuclidinyl Benzilate; Ra | 1989 |
Phenomenology and pathophysiology of antipsychotic withdrawal symptoms.
Topics: Adult; Agoraphobia; Anxiety Disorders; Depressive Disorder; Female; Humans; Middle Aged; Substance W | 1989 |